A 26‐week feasibility study comparing the efficacy and safety of modified‐release prednisone with immediate‐release prednisolone in newly diagnosed cases of giant cell arteritis

Publisher: John Wiley & Sons Inc

E-ISSN: 1756-185x|21|1|285-291

ISSN: 1756-1841

Source: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.21, Iss.1, 2018-01, pp. : 285-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content